Malignancy Risk Associated With Mycophenolate Mofetil or Azathioprine in Patients With Fibrotic ILD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Chest
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Malignancy Risk Associated With Mycophenolate Mofetil or Azathioprine in Patients With Fibrotic Interstitial Lung Disease
Chest 2022 Jun 01;161(6)1594-1597, SD Lok, AW Wong, YH Khor, CJ Ryerson, KA JohannsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.